DEVELOPING MESOPOROUS SILICA NANOPARTICLE-BASED STIMULI-RESPONSIVE NANOCARRIERS FOR DELIVERY OF SMALL MOLECULE THERAPEUTICS AGAINST COLON CANCER CELLS